Yi Wang
11Patents
5h-index
15Co-inventors
52Inventor score
Filing activity: Mar 15, 2017 → Jul 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10377743B2 | Inhibitors of RAS and methods of use thereof | Chemistry; Metallurgy | 29 | Active |
| US10736897B2 | Compounds and methods of use thereof for treatment of cancer | Chemistry; Metallurgy | 26 | Active |
| US10745385B2 | Covalent inhibitors of KRAS | Chemistry; Metallurgy | 16 | Active |
| US10781218B2 | Substituted inhibitors of menin-MLL and methods of use | Chemistry; Metallurgy | 13 | Active |
| US10752639B2 | Bridged bicyclic inhibitors of menin-MLL and methods of use | Human Necessities | 5 | Active |
| US11673898B2 | Substituted inhibitors of menin-MLL and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11377441B2 | Covalent inhibitors of KRAS | Chemistry; Metallurgy | 3 | Active |
| US11639346B2 | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS | Chemistry; Metallurgy | 2 | Active |
| US11944627B2 | Methods for treating hematological malignancies and Ewing's sarcoma | Human Necessities | 0 | Active |
| US11555041B2 | Bridged bicyclic inhibitors of menin-MLL and methods of use | Human Necessities | 0 | Active |
| US12134620B2 | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.